Inventor · disambiguated record
Ou Li
Also filed as: LI OU
6 granted patents·2 pending applications·9 citations·filing 2016–2023
76Inventor score
Top patents by PatentIndex Score
8 records- 0182US10167334B2Treatment of cancer using anti-TGF-BETA and PD-1 antibodiesXOMA TECHNOLOGY LTD·Filed 2016·Granted Jan 1, 2019·4 cites·15 claims
- 0280US10253101B2Antibody fragments against the insulin receptor and uses thereof to treat hypoglycemiaXOMA US LLC·Filed 2016·Granted Apr 9, 2019·2 cites·33 claims
- 0378US2023416354A1Treatment of cancer using inhibitors of tgf-beta and pd-1XOMA TECHNOLOGY LTD·Filed 2023·Application pending·0 cites
- 0475US10858428B2Antibodies that bind interleukin-2 and uses thereofXOMA US LLC·Filed 2017·Granted Dec 8, 2020·2 cites·31 claims
- 0574US10683347B2Treatment of cancer using anti-TGF-β and anti-PD-1 antibodiesXOMA TECHNOLOGY LTD·Filed 2018·Granted Jun 16, 2020·1 cites·16 claims
- 0668US11685775B2Method of increasing the ratio of effector T cells to regulatory T cells in a tumor by administering to a subject a TGF-beta inhibitor and a PD-1 antibodyXOMA TECHNOLOGY LTD·Filed 2020·Granted Jun 27, 2023·0 cites·16 claims
- 0762US12234285B2Antibodies that bind interleukin-2 and uses thereofXOMA US LLC·Filed 2020·Granted Feb 25, 2025·0 cites·14 claims
- 0851US2018251562A1Antibody Fragments Against the Insulin Receptor and Uses Thereof to Treat HypoglycemiaXOMA US LLC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ou Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →